Press Releases September 4, 2026 08:53 AM

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

DSS, Inc. cancels planned public offering citing limited shelf registration capacity, explores alternative capital-raising strategies.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
DSS

DSS, Inc. announced it will not proceed with its previously planned public offering of Common Stock due to limited capacity under its existing shelf registration statement. The company continues to evaluate other capital-raising options and remains focused on creating shareholder value. DSS operates across multiple sectors including product packaging, biotechnology, commercial lending, and investment management.

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering
DSS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • DSS, Inc. cancels its planned public offering of Common Stock due to limited shelf registration capacity.
  • The company is exploring other capital-raising alternatives to support its diverse business lines.
  • DSS operates in multiple sectors: product packaging, biotechnology, commercial lending, and securities and investment management, impacting these economic areas.

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that after further consideration, the Company determined not to proceed with its previously announced proposed public offering of Common Stock due to the limited capacity available under its existing shelf registration statement.

The Company continues to evaluate its capital-raising alternatives and remains committed to creating value for shareholders. The Company’s Common Stock is traded on the NYSE American LLC under the symbol “DSS”.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and no offering of securities is being made by means of this press release. No offer, solicitation, or sale of securities is being made in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DSS, Inc.

DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

For investor and media inquiries or additional information, please contact:

Investor Contact:
DSS, Inc.
Investor Relations
[email protected]
+1 (585) 565-2422


Risks

  • Limited capacity under current shelf registration restricts DSS's immediate fundraising ability, which could impact liquidity and growth plans.
  • Dependence on successful capital-raising efforts introduces uncertainty to the company’s ability to fund operations and expansion.
  • Operating across diverse sectors exposes the company to sector-specific risks including regulatory changes, market volatility, and economic downturns in areas such as biotechnology and commercial lending.

More from Press Releases

BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows Sep 4, 2026 SoundHound AI Completes Acquisition of LivePerson, Creating a World-Leading Omnichannel Conversational AI Powerhouse Sep 4, 2026 Merit Medical to Participate in Upcoming Investors Conferences in September Sep 4, 2026 Imperial Petroleum Inc. Announces the Date for the Release of the Second Quarter and Six Months 2026 Financial and Operating Results, Conference Call and Webcast Sep 4, 2026 Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference Sep 4, 2026